I am an avocado farmer who sometimes treats liver cancer at @UCSDHealth @ucsd_IR
San Diego, CA
Joined January 2012
- Tweets195
- Following91
- Followers289
- Likes147
Zach Berman MD retweeted
**NEW IN JVIR**
➡️ Full Article: brnw.ch/21x6vOM
#Y90 #TARE #GlassMicrospheres #Dosimetry #InterventionalOncology #MedEd
🔥Hot off press our new JVIR study🔥: Single-session ablative TARE was associated with 27.4% lower charges, treatment 15 days sooner, and 42.6% fewer travel miles than regular TARE.
doi.org/10.1016/j.jvir.2026.…
@JVIRmedia @bsc_io_e @SIRspecialists @SIO_Central @BeauToskichMD
Zach Berman MD retweeted
Hot off the press. Y90 continues to expand reach in bridging/downstaging #HCC (2025 data) @JVIRmedia @DieHCCDie @BeauToskichMD @laurakulik1
doi.org/10.1016/j.jvir.2026.…
This week's Journal Club is the COLLISION trial, the Phase 3 RCT looking at surgery vs Ablation for CRC mets. Check it out here: youtu.be/LeteGwoR63I
@SIRspecialists @SIO_Central
In this weeks 🔥 Rapid Fire 🔥 Interventional Oncology video we review: The LEGACY Study (Salem et al., Hepatology 2021). A pivotal Y90 paper!
youtu.be/ii_zkAwNCBo
#HCC #Y90 #InterventionalRadiology @ucsd_ir @SIRspecialists @SIO_Central @_backtable #meded
I decided to try something new, video! I read and evaluated the prospective PROACTIF study for Y90 in HCC, and summarized my thoughts. Let me know what you think!
youtube.com/watch?v=StpsUyns…
@bsc_io_e @BeauToskichMD @SIRspecialists @cirsesociety @bayouteazy @ucsd_ir
Zach Berman MD retweeted
#Y90 Radiation Lobectomy.
Downstage and remodel the liver for the big win.
youtu.be/TiDxmaoxfZQ?is=O73Y…
Zach Berman MD retweeted
We’re proud to spotlight Dr. Beau Toskich @BeauToskichMD , our Director of Interventional Oncology, featured on the BackTable VI Podcast @_backtable alongside Dr. Zach Berman @ZTBerman and Dr. Venkatesh Krishnasamy @kavikrishVIR discussing CPN & Radiation Segmentectomy in liver cancer. The conversation highlights emerging research, including our latest multicentre COBRAS study and innovative strategies advancing hepatocellular carcinoma (HCC) care for improved patient outcomes. – at Jacksonville Beach, FL
Zach Berman MD retweeted
Can the right dosimetry approach turn palliative Y-90 into a curative tool?
In this episode of our 2026 HCC Creator Weekend, Drs. @ZTBerman, Nima Kokabi, and @riadsalemIR break down the evolving world of Y-90 dosimetry, from moving beyond outdated body surface area calculations to tailoring treatment based on tumor biology, liver function, and clinical goals.
This podcast is supported by an educational grant from Sirtex and Boston Scientific.
📲 Listen to the full episode the BackTable app: na2.hubs.ly/H05M2yz0
#InterventionalRadiology #Y90 #HCC #IR #VI649
Zach Berman MD retweeted
From fellowship jitters to clinical confidence, Dr. Parikh reflects on early career growth, mentorship, and learning to balance ambition with well-being as an #IRad. Listen to our latest episode on the Kinked Wire!
sirweb.org/kinked-wire/episo…
Zach Berman MD retweeted
In treatment-naive HCC, radiation segmentectomy before liver transplant achieved high rates of complete pathologic necrosis. bit.ly/4a03fBf @ZTBerman @BeauToskichMD @MayoClinicFL_IR @UCSD_IR @DieHCCDie @cyndlg @bayouteazy @shamaryoungmd
Zach Berman MD retweeted
Thank you Dr. Parikh for our newest ECS podcast episode released for #WomensHealthMonth. In this episode Dr. Parikh shares how, she got interested in women's health interventions and her transition from residency into building a practice as an #IRad.
sirweb.org/kinked-wire/episo…
Zach Berman MD retweeted
Proud moment for our team as our residents, Cynthia @cyndlg and Ali, under the mentorship of our Director of Interventional Oncology, Dr. Beau Toskich @BeauToskichMD played a significant role in the publication of this important multicenter study which showed high rates of complete tumor necrosis with optimized Y90 radiation segmentectomy for HCC prior to liver transplant.
In collaboration with seasoned physicians across multiple centres, this reflects true multidisciplinary excellence.
Published in RSNA Radiology, the full study can be read at: doi.org/10.1148/radiol.25192…. @RSNA @SIRspecialists @SIRRFS – at Jacksonville Beach, FL
Setting a new standard for glass Y90 RadSeg! Big multicenter national studies are the way of the future; confirming what we see in small trials.
COBRAS is published in Radiology.
91% CPN PPV with optimized Y90 radiation segmentectomy for HCC as bridge to transplant.
Congratulations to the consortium and thank you for your dedication.
#Y90 #HCC #TRANSPLANT
pubs.rsna.org/doi/10.1148/ra…
@SIRspecialists
@SIO_Central
@cirsesociety
@ECIOcongress
@ASTSChimera
@AASLDtweets
@radiology_rsna
Zach Berman MD retweeted
Publication Alert
A new study from our team has been published:
“Incidence of Gastrointestinal Adverse Events Following Left Hepatic Lobe Radiation Segmentectomy for the Treatment of Hepatocellular Carcinoma.” @cyndlg
@BeauToskichMD @FZIslamMD
Read the full article here:
link.springer.com/article/10… – at Jacksonville Beach, FL
Zach Berman MD retweeted
💚 Fantastic effort establishing consensus and future efforts for #cholangiocarcinoma.
DOWNSTAGING unresectable liver-only CCA with #Y90 TARE is officially a FIRST-LINE approach. 🧩
🔵TARE allows for:
- ⬆️ Tumor response and control.
- ⬆️ Future liver remnant growth.
(🗝️ Protect FLR)
- 💉 Concurrent systemic therapy.
- ⌚ Biological test of time.
Fight for your patients' BIG WIN. 🧩
@curecc @ASCO @myESMO @SIO_Central @SIRspecialists @FlavioRochaMD @JavleMilind
Zach Berman MD retweeted
In this prospective study in participants with HCC, ethiodized oil–based TACE using an anhydrous cisplatin suspension resulted in better complete tumor response and survival compared with the conventional aqueous cisplatin emulsion. @CUHKMedicine bit.ly/48ncl9T
TACE has fallen out of favor to other modern alternatives - but this is an imprtnt RCT improving ORR, PFS, AND OS with a simple but better technique. tinyurl.com/32jhkbts
Standardization of TACE in future trials critically important!
@radiology_rsna @ucsd_ir @SIO_Central
Zach Berman MD retweeted
Part 3 of the HCC Webinar Series: Ongoing Critical Trials of Combination Locoregional Therapy and Immunotherapy in the Liver, is Tuesday, 4 Nov. | 7 p.m. ET.
Featuring: @ZTBerman, Adam Burgoyne, MD, PhD, @kiremagarciamd, and @ChrisDMaloneVIR.
Register: bit.ly/3WQcaOL
Zach Berman MD retweeted
Passionate about clinical research?
Apply for the Interventional Oncology Clinical Trials Methodology Workshop — a five-day immersive program at the @Penn focused on trial design, regulatory strategy, and data innovation.
📅 19-23 May, 2026
Apply here: bit.ly/499UUvf
